Tactical 10–15% trim preserves structural floor while avoiding the 9/8 Overweight error pattern; re-engage on technical repair, deep value flush, or macro relief
Underweight at 10–15% trim is the disciplined expression—preserving the structural floor (12x forward earnings, 24% ROE, $12B FCF, $1.78B net cash, 7.7% shareholder yield) while reducing exposure to the alpha-bleed pattern. The 9/18 reflection is dispositive on sizing: trim smaller (10–20%) rather than full exit to capture the bear-case compression and mean-reversion option value. Passive Hold has bled -3.2% alpha in recent instances; aggressive 40–50% trim forfeited +1.1% alpha despite structural floor holding. Probability-weighted return profile: Bear ~35% at $165–172, Base ~45% at $175–190, Bull ~20% at $215–235. The expected return is slightly negative with optionality, but better than the confirmed alpha-killer pattern of passive Hold and better than forfeiting upside through oversized trim.
| Position | Action |
|---|---|
| Current weight | Execute 10–15% trim immediately (front half of window) |
| Close below $170 on elevated volume | Additional 10% trim, signaling structural-floor failure |
| Path A re-engagement (technical repair): Daily close above $197 (200 SMA) with volume >7M shares + positive MACD histogram + RSI >50 | Scale back to benchmark weight; revisit Overweight |
| Path B re-engagement (deep value flush): Pullback to $170 with bullish MACD divergence + RSI >35 + declining volume on flush | Add 5–10% to position |
| Path C re-engagement (macro relief): 10Y below 4.5% + Fed dovish pivot signal | Re-engage at 50% benchmark weight |
| Q4 FY26 earnings beat-and-raise with FY27 guide ≥6% organic + GenAI bookings acceleration | Upgrade to Hold at benchmark weight |
| Q4 FY26 earnings miss with cautious FY27 guide or goodwill commentary | Downgrade to Underweight at 60–70% benchmark weight |
ACN is a high-quality compounder at a cyclical discount, with $12B+ in annual FCF, a net cash balance sheet, and a commanding position in the enterprise AI transformation super-cycle — all while trading at 12x forward earnings with a 3:1 risk/reward to $220-240.
| Indicator | Value | Signal |
|---|---|---|
| 50 SMA | $173.77 | bullish |
| 200 SMA | $196.19 | bearish |
| 10 EMA | $184.39 | bearish |
| RSI(14) | 45.80 | neutral |
| MACD | 2.20 | bearish |
| MACD Histogram | -1.70 | bearish |
| Bollinger Middle | $185.85 | neutral |
| Bollinger Upper | $197.09 | neutral |
| Bollinger Lower | $174.61 | bearish |
| ATR(14) | $7.32 | neutral |
| VWMA | $185.99 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Daily close above $197 (200 SMA) with volume >7M shares + positive MACD histogram + RSI >50
Then: Scale back to benchmark weight; revisit Overweight
↩ rebuts: “Growth deceleration and margin pressure concerns”
EV: +25-35% ($220-240) · concedes: IBM's 12% TTM decline on deal slippage shows consulting peers face execution risk; ACN does use M&A to augment capabilities rather than purely organic growth; The +6% post-Anthropic move partially reflects near-term news pricing
ACN is not a quality compounder at a discount but a falling knife wrapped in narrative—the June 26% structural break, decelerating revenue, levering balance sheet, AI existential threat to labor arbitrage model, and failing technicals at the 200 SMA all point to a mature business at the appropriate valuation with further downside risk toward $150-160.
EV: $150-160 · concedes: Operating margin did expand to 17.0%; FCF generation is substantial at $12.1B TTM; RSI at 45.8 is technically 'neutral' (though momentum has rolled over); MACD is still technically positive at 2.20; The lower Bollinger band could provide a bounce
→ vs conservative: Anchoring on a stock that dropped 9% after rallying 51% from $135 to $195; requiring 'perfect setup' of multiple technical confirmations (10 EMA, VWMA, MACD, RSI divergence) causes paralysis, not discipline; Bollinger lower band at $174.61 is an entry, not a warning; waiting for confirmation historically cost 15-25% more on quality names
→ vs conservative: VWMA at $186 with price at $177 is being labeled as distribution, but the 9% pullback on macro fears after a 51% bounce is more consistent with final shakeout before re-rating, not a distribution top
→ vs neutral: Multiple compression thesis is already in the price—stock at 12x forward earnings already reflects doom scenario; ACN at 12x with $14.67 EPS implies $205 at 14x multiple before growth
→ vs neutral: IBM comparison is flawed—IBM down 12% TTM due to GenAI disruption from hyperscalers; ACN has billion-dollar Anthropic partnership and $3B+ GenAI bookings, creating moat IBM lacks
→ vs neutral: Rate sensitivity argument ignores that high-cash-flow, high-capital-return businesses with 7.7% shareholder yield become MORE valuable in high-rate environments, not less; dividend and buyback yield compensate for duration concerns
→ vs neutral: Trefis 'too late' framing ignores that stock is still down 32% YTD and trading at half its 3-year high; easy money remains for conviction buyers at these levels
| 7-Day Change | -9.0% ($195.00 → $177.41) | bearish |
Support: 174.61 · 173.77 · 170 | Resistance: 184 · 186 · 195 · 197
The post-June crash recovery has stalled at the 200 SMA ($196.19) and entered active distribution, with all short-term moving averages and momentum indicators turning bearish within the last week. The 50 SMA at $173.77 provides the final support layer before the recovery thesis is invalidated; a break below $174.61 (Bollinger lower band) would target $170. No new buying is warranted until price reclaims the 10 EMA ($184.39) and VWMA ($185.99) on volume. Existing longs should tighten stops to $174, while tactical shorts on failed bounces toward $184-$186 offer favorable risk/reward in the current configuration.
Market Cap
$108.56B
PE Ratio (TTM)
14.17x
Forward PE
12.09x
PEG Ratio
1.33
Price to Book
3.40x
EPS (TTM)
$12.52
Forward EPS
$14.67
Book Value per Share
$52.12
Dividend Yield
3.55%
Beta
1.09
52-Week High
$291.09
52-Week Low
$118.15
50-Day Average
$173.89
200-Day Average
$198.87
Revenue (TTM)
$73.10B
Revenue FY2025
$69,673M
Revenue FY2024
$64,896M
Revenue FY2023
$64,112M
Revenue FY2022
$61,594M
Gross Profit FY2025
$22,235M
Gross Margin FY2025
31.9%
Gross Margin FY2022
32.0%
Operating Income FY2025
$10,841M
Operating Margin FY2025
15.6%
Operating Margin FY2022
15.2%
Net Income FY2025
$7,678M
Net Income FY2022
$6,877M
Diluted EPS FY2025
$12.15
Diluted EPS FY2022
$10.71
Profit Margin (Net)
10.7%
Operating Margin (TTM)
17.0%
EBITDA Margin
17.7%
Return on Equity (ROE)
24.4%
Return on Assets (ROA)
10.9%
Cash & Equivalents
$10,165M
Total Debt
$8,389M
Net Debt
-$1,778M
Debt/Equity
25.0%
Current Ratio
1.34
Working Capital
$7,329M
Goodwill + Intangibles
$27,822M
Stockholders' Equity
$31,891M
Operating Cash Flow FY2025
$11,474M
Free Cash Flow FY2025
$10,874M
Free Cash Flow (TTM)
$12.09B
Capital Expenditures FY2025
$600M
Acquisitions FY2024
$6,554M
Dividends Paid FY2025
$3,700M
Buybacks FY2025
$4,619M
Total Shareholder Yield
7.7%
Q3 FY2026 Revenue
$18,718M
Q3 FY2026 Diluted EPS
$3.80
Q3 FY2026 Operating Margin
17.0%
Q1 FY2026 Revenue
$18,742M
Q2 FY2026 Revenue
$18,044M
GenAI Bookings
>$3B
Shares Outstanding Q3 FY2026
615.6M
Treasury Stock May 2026
$11.95B
FY25 Special Charges
$615M
FY25 Interest Expense
$228.6M
FY2026 YTD Revenue Growth
~5%
4Y Revenue CAGR
4.2%
FY2026 Full Year Revenue Guidance
$73-74B
Strengths
Concerns
Accenture is a high-quality IT services compounder trading at a discounted forward P/E of 12.1x with ~17% expected EPS growth, supported by a 3.55% dividend yield and ~7.7% total shareholder yield (dividends + buybacks). Revenue grew 13.1% in FY2025 to $69.7B with operating margin expanding to 15.6%, while TTM FCF of $12.1B provides robust coverage for capital returns and balance sheet flexibility (net cash position of ~$1.8B).
Macro: Macro backdrop has materially deteriorated and is now the dominant driver for high-multiple long-duration equities like ACN. Treasury yields surged to pre-GFC highs: 10Y at ~5% (highest since 2007) and 30Y at highest since 2004. Fed expectations have inverted with Polymarket showing 97% probability of ZERO Fed rate cuts in 2026 (all '≥6 cuts' contracts at 0%). Inflation remains a concern with 16% probability of 2026 inflation exceeding 4.5%, while Jamie Dimon noted "not clear we've slayed inflation." Oil is near $100 with geopolitical uncertainty around Iran. Nvidia led tech stocks lower as yields surged, and IBM (closest ACN peer) is down 12% TTM due to large-deal slippage—a cautionary signal for ACN's deal-pipeline. Tech stocks haven't been this cheap since OpenAI launched ChatGPT (bullish relative valuation, conditional on yields stabilizing).